ArticleBioengineered2021

LIM domain-containing 2 (LIMD2) promotes the progress of ovarian cancer via the focal adhesion signaling pathway.

Lixin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.